Cellular Repair & Recovery
Thymosin Alpha-1 / KPV
Peptide blend
Thymosin Alpha-1 and KPV blend
Research context
This preparation combines Thymosin Alpha-1, studied in Toll-like receptor and dendritic cell signalling, with KPV, studied in NF-κB pathway modulation. Each is characterised independently in the published literature.
Common assays: Component identity by LC-MS · Purity per component
Specification
| Designation | Peptide blend |
|---|---|
| Full name | Thymosin Alpha-1 and KPV blend |
| Components | Thymosin Alpha-1 · KPV |
| Formats | 15 mL Nasal Spray · 15 mL Oral Spray |
| Solubility | Supplied in metered spray format |
| Storage | Refrigerated 2–8 °C |
Common questions
Can a 28-residue peptide and a tripeptide be resolved in the same run?
Yes — the substantial difference in size and hydrophobicity gives wide retention time separation under standard RP-HPLC conditions.
Same pathway
Related compounds
BPC-157
Body Protection Compound-157
A synthetic pentadecapeptide derived from a gastric juice sequence, studied in migration and angiogenesis models.
TB-500
Thymosin beta-4 fragment
A synthetic fragment corresponding to the actin-binding domain of thymosin beta-4.
BPC-157 / TB-500
Peptide blend
A prepared blend of the two most extensively studied compounds in the repair signalling literature.